Evidence map›Paper›PMID 22022263›Full record

ArticlePLoS pathogens2011

A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Moriah L Szpara, Yolanda R Tafuri, Lance Parsons, S Rafi Shamim, Kevin J Verstrepen, Matthieu Legendre, L W Enquist

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Moriah L SzparaDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America.
Yolanda R Tafuri
Lance Parsons
S Rafi Shamim
Kevin J Verstrepen
Matthieu Legendre
L W Enquist
Princeton University · USCentre National de la Recherche Scientifique · FRKU Leuven · BE

Funding

Spatial Patterning During DevelopmentP50GM071508 · NIGMS · PRINCETON UNIVERSITY · PI SHENK, THOMAS E · 2004 to 2013
$30.6M
CENTER FOR NEUROANATOMY WITH NEUROTROPIC VIRUSES: COMPARATIVE MEDICINEP40RR018604 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRICK, PETER · 2004 to 2011
$6.5M
HERPES SIMPLEX VIRUS FC RECEPTORR01AI033063 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI FRIEDMAN, HARVEY MICHAEL · 1992 to 2009
$2.0M
European Research Council 241426NCRR NIH HHS P40 RR 018604NCRR NIH HHS P40 RR018604NIAID NIH HHS R01 AI 033063NIAID NIH HHS R01 AI033063NIGMS NIH HHS P50 GM071508
6 · The paper itself

Abstract

Alphaherpesviruses are widespread in the human population, and include herpes simplex virus 1 (HSV-1) and 2, and varicella zoster virus (VZV). These viral pathogens cause epithelial lesions, and then infect the nervous system to cause lifelong latency, reactivation, and spread. A related veterinary herpesvirus, pseudorabies (PRV), causes similar disease in livestock that result in significant economic losses. Vaccines developed for VZV and PRV serve as useful models for the development of an HSV-1 vaccine. We present full genome sequence comparisons of the PRV vaccine strain Bartha, and two virulent PRV isolates, Kaplan and Becker. These genome sequences were determined by high-throughput sequencing and assembly, and present new insights into the attenuation of a mammalian alphaherpesvirus vaccine strain. We find many previously unknown coding differences between PRV Bartha and the virulent strains, including changes to the fusion proteins gH and gB, and over forty other viral proteins. Inter-strain variation in PRV protein sequences is much closer to levels previously observed for HSV-1 than for the highly stable VZV proteome. Almost 20% of the PRV genome contains tandem short sequence repeats (SSRs), a class of nucleic acids motifs whose length-variation has been associated with changes in DNA binding site efficiency, transcriptional regulation, and protein interactions. We find SSRs throughout the herpesvirus family, and provide the first global characterization of SSRs in viruses, both within and between strains. We find SSR length variation between different isolates of PRV and HSV-1, which may provide a new mechanism for phenotypic variation between strains. Finally, we detected a small number of polymorphic bases within each plaque-purified PRV strain, and we characterize the effect of passage and plaque-purification on these polymorphisms. These data add to growing evidence that even plaque-purified stocks of stable DNA viruses exhibit limited sequence heterogeneity, which likely seeds future strain evolution.

Indexed as

Genetic VariationMicrosatellite RepeatsAlphaherpesvirinaeAmino Acid SequenceAnimalsBase SequenceGenome, ViralHerpesvirus 1, HumanHerpesvirus 1, SuidHerpesvirus 3, HumanHerpesvirus VaccinesHumansMolecular Sequence DataPolymorphism, GeneticPseudorabies VaccinesSequence AlignmentHerpesvirus VaccinesPseudorabies VaccinesViral Proteins

Identifiers

PMID22022263
PMCPMC3192842
OpenAlexW2140516842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.